http://ghpro.dexisonline.com/info-consultants.png   http://ghpro.dexisonline.com/info-usaid.png

Global

Delivering Comprehensive Supportive Care to People With Drug-Resistant Tuberculosis

Drug-resistant tuberculosis (DR-TB) is a significant global health threat, with an estimated 600,000 cases occurring annually. The United States Government committed to address DR-TB, both domestically and internationally, in the National Action Plan for Combating Multidrug-Resistant Tuberculosis. This Practical Toolkit is part of that effort.

Performance (Endline) Evaluation of the Advancing Partners and Communities Project

The Advancing Partners & Communities (APC) Project is a five-year USAID cooperative agreement with the John Snow, Inc. Research & Training Institute, in collaboration with FHI 360, funded from October 2012, with a two-year extension until September 2019. This evaluation assessed the extent to which APC has achieved its objectives and identified community-based family planning (CBFP) activities that might warrant future investment.

Linkages Across the Continuum of HIV Services for Key Populations Affected by HIV (LINKAGES): Mid-Term Performance Evaluation

The USAID-funded Linkages Across the Continuum of HIV Services for Key Populations Affected by HIV (LINKAGES) project, implemented in 30 countries, aims to increase the availability of and demand for HIV services for key populations and strengthen national government and civil society capacity to deliver these services. The objectives of the mid-term evaluation were to: assess project effectiveness, planning, management, service delivery, and sustainability; identify constraints to implementation; and propose recommendations for improvements.

USAID Emerging Pandemic Threats 2 Program Evaluation

The Emerging Pandemic Threats 2 (EPT2) program assists countries to reduce the risks and impact of
pandemic threats, applying a One Health (OH) approach. Implementing partners include three
projects—PREDICT 2, One Health Workforce, and the Preparedness and Response Project—and
partners the Food and Agriculture Organization, and the World Health Organization. This midterm
evaluation identifies strengths and challenges in EPT2, re-evaluates its initial priorities in light of the

PERFORMANCE EVALUATION OF THE EVIDENCE PROJECT: Ensuring that today’s research is tomorrow’s programs

USAID’s Office of Population and Reproductive Health’s flagship implementation science project,
the Evidence Project, was awarded in September 2013 as a five-plus-five-year cooperative
agreement. To inform decisions about future programming, the USAID management team
supported a performance evaluation through the Global Health Program Cycle Improvement
Project (GH Pro). A three-person evaluation team, including one external consultant and two
USAID staff members, conducted an evaluation, between January and April 2017, that included

Mid-term Management Review of the Challenge TB Project

The purpose of this mid-term management review is to assess the overall project management, successes, and opportunities for improvement of the Challenge TB (CTB) project. The results of the management review will be used to provide feedback and recommendations to CTB on project operations and management. The following evaluation questions were addressed:

1. Is the project aligned with the guiding principles outlined in the RFA and CTB cooperative agreement program description and work plans? Is it “on track” to deliver the committed results?

Leadership, Management and Governance Project: End of Project Evaluation

This end-of-project technical performance evaluation of the Leadership, Management and Governance (LMG) Project was commissioned by USAID’s Bureau for Global Health (GH), Office of Population and Reproductive Health (PRH) to provide feedback to USAID in two main areas: effectiveness and sustainability of leadership, management and governance interventions and inform future programming of the GH and the Democracy, Conflict and Humanitarian Assistance (DCHA) bureaus.

Mid-Term Program Evaluation of the MalariaCare Project

The MalariaCare Project is a five-year cooperative agreement led by PATH and funded by the U.S. Agency for International Development (USAID) under the President's Malaria Initiative (PMI). The project is one of four flagship projects—managed centrally by USAID/Global Health Bureau/Office of Health, Infectious Diseases, and Nutrition/Malaria Division—accessible to Missions to support the malaria case management efforts of PMI. The project aims to scale up high-quality case management services, both diagnosis and treatment, for malaria and other febrile illnesses.

Pages